A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background The accuracy and convenience of pen devices for insulin injection have improved quality of life for patients with insulin-treated diabetes mellitus (DM). Prefilled, disposable pens have the advantage of simplicity, with minimal training and attention required and no installation of new cartridges necessary. Objective The aim of this study was to assess patient preference, efficacy, and safety profiles of a prefilled, disposable pen (FlexPen) and conventional vial/syringe injection method for insulin injection therapy among patients with DM. Methods In a multicenter, randomized, open-label, crossover study, patients with type 1 or 2 DM were transferred from previous QD or BID conventional insulin therapy to a mixture of 70% insulin aspart protamine suspension and 30% insulin aspart injection (NovoLog Mix 7030) for 4 weeks of dose optimization using their usual type of syringe. Patients were then randomly assigned to use either vial/syringe or a prefilled, disposable pen to inject the biphasic insulin aspart 7030 mixture for the next 4 weeks, followed by 4 weeks of use of the other injection device. Efficacy, safety profiles, and patient preference for the delivery systems were compared. Results A total of 121 patients (mean [SD] age, 57.0 [12.4] years; age range, 28-81 years; mean [SD] body mass index, 31 [5.5] kg/m(2)) were enrolled. One hundred three patients completed the study. Seventy-four percent of patients (78105) indicated a preference for the pen over the…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Injecting insulin with a syringe or pen (136-147) is the insulin delivery method used by most people with diabetes (142,148), although inhaled insulin is also available.”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [138]
Citations
Cites
When oral agents fail: practical barriers to starting insulin
Korytkowski, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802173 · Cited by 448
Self-citationBradley, C., & Lewis, K. S. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01421.x · Cited by 379
Patient perceptions of diabetes and diabetes therapy: assessing quality of life
Bradley, C., & Speight, J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.279 · Cited by 362
Graff, M. R., & McClanahan, M. A. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80058-1 · Cited by 149
Insulin delivery using pen devices: Simple-to-use tools may help young and old alike
Bohannon, N. J. V. (1999) · Postgraduate Medicine · doi:10.3810/pgm.1999.10.15.751 · Cited by 113
Kadiri, A., Chraibi, A., Marouan, F. F., Ababou, M. R., Guermai, N. E., Wadjinny, A., Kerfati, A., Douiri, M., Bensouda, J., Belkhadir, J., et al. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00055-2 · Cited by 97
Experience of pain from insulin injections and needle‐phobia in young patients with IDDM
Hanas, R., & Ludvigsson, J. (1997) · Practical Diabetes International · doi:10.1002/pdi.1960140404 · Cited by 76
Effect of patient-selected intensive insulin therapy on quality of life
Chantelau, E. A., Schiffers, T., Schütze, J., & Hansen, B. (1997) · Patient Education and Counseling · doi:10.1016/s0738-3991(96)00964-0 · Cited by 70
Insulin improves well-being for selected elderly type 2 diabetic subjects
Reza, M., Taylor, C., Towse, K., Ward, J. D., & Hendra, T. J. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00327-8 · Cited by 68
Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations
Hörnquist, J. O., Wikby, A., Andersson, P., & Dufva, A.-M. (1990) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(90)90065-2 · Cited by 64
Research works printed but not linked: 4
- Da Costa, 1997, Coordinated approach to insulin transfer in the older type 2 client, J Diabetes Nurs, 1, 123
- Bashoff, 1995, Insulin therapy and the reluctant patient. Overcoming obstacles to success, Postgrad Med, 97, 93, 10.1080/00325481.1995.11945960 · DOI
- Bohannon, 1999, Insulin delivery using pen devices. Simple-to-use tools may help young and old alike, Postgrad Med, 106, 61, 10.3810/pgm.1999.10.15.751 · DOI · Paper page
- Bohannon, 1999, Insulin delivery using pen devices. Simple-to-use tools may help young and old alike, Postgrad Med, 106, 68, 10.3810/pgm.1999.10.15.751 · DOI · Paper page
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.004 · Cited by 266
Metadata
- Authors
- Korytkowski, M., Bell, D., Jacobsen, C., Suwannasari, R., & FlexPen® Study Team
- Affiliations
- University of Pittsburgh Medical Center (US)
- University of Alabama at Birmingham (US)
- Novo Nordisk (United States) (US)
- Corresponding author
- Korytkowski, Mary
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 25
- Issue
- 11
- Pages
- 2836-2848
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W1982825166
- Cited by
- 267
- References
- 15
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 15 · 2015: 9 · 2014: 11 · 2013: 15 · 2012: 15
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Clinical Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- insulin injection devices, patient preferences, type 1 diabetes, type 2 diabetes, insulin aspart, injection pain, injection site swelling
- MeSH terms
- Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Disposable Equipment, Female, Humans, Injections, Subcutaneous, Insulin, Male, Middle Aged, Patient Compliance, Quality of Life, Syringes, Patient Satisfaction, Cross-Over Studies, Insulin Aspart
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. https://app.cochat.ai/papers/10.1016/s0149-2918(03)80337-5
- The paper
- Korytkowski, M., Bell, D., Jacobsen, C., Suwannasari, R., & FlexPen® Study Team. (2003). A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(03)80337-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.